BeOne Medicines AG Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	252,853	261,671	152,765	147,345	178,113	217,115
Market Cap Growth	11.74%	71.29%	3.68%	-17.27%	-17.96%	19.19%
Enterprise Value	224,172	238,190	139,855	128,433	144,042	192,027
Last Close Price	174.50	179.30	109.20	110.10	134.20	161.00
PE Ratio	60.43	117.17	-	-	-	-
PS Ratio	5.65	6.29	5.16	7.67	16.13	23.67
PB Ratio	6.73	7.71	5.90	5.33	5.21	4.54
P/TBV Ratio	6.99	7.82	5.99	5.42	5.26	4.58
P/FCF Ratio	27.35	35.70	-	-	-	-
P/OCF Ratio	23.86	29.82	-	-	-	-
EV/Sales Ratio	5.01	5.73	4.72	6.69	13.05	20.94
EV/EBITDA Ratio	34.13	52.87	-	-	-	-
EV/EBIT Ratio	42.75	68.44	-	-	-	-
EV/FCF Ratio	24.25	32.49	-	-	-	-
Debt / Equity Ratio	0.25	0.46	0.32	0.26	0.14	0.11
Debt / EBITDA Ratio	1.40	3.28	-	-	-	-
Debt / FCF Ratio	1.01	2.12	-	-	-	-
Net Debt / Equity Ratio	-0.76	-0.58	-0.46	-0.63	-0.90	-0.97
Net Debt / EBITDA Ratio	-4.45	-4.40	3.86	2.00	2.28	4.25
Net Debt / FCF Ratio	-3.10	-2.70	2.44	1.30	2.16	3.80
Asset Turnover	-	0.76	0.65	0.40	0.19	0.17
Inventory Turnover	-	1.21	1.30	1.09	1.09	0.99
Quick Ratio	3.26	2.97	1.51	1.97	3.22	4.45
Current Ratio	3.73	3.41	1.80	2.32	3.55	4.76
Return on Equity (ROE)	-	7.46%	-18.77%	-22.26%	-38.11%	-29.15%
Return on Assets (ROA)	-	3.96%	-6.06%	-12.39%	-15.00%	-12.72%
Return on Invested Capital (ROIC)	37.33%	16.75%	-37.34%	-139.72%	-563.24%	-
Return on Capital Employed (ROCE)	10.10%	7.00%	-15.30%	-30.20%	-36.40%	-20.70%
Earnings Yield	1.65%	0.85%	-3.28%	-4.67%	-8.77%	-5.24%
FCF Yield	3.66%	2.80%	-3.22%	-9.12%	-7.98%	-5.61%
Buyback Yield / Dilution	-10.10%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%